Navitor

Developing therapeutics for age related, rare and genetic diseases by targeting the central regulator of nutrient signaling.

placeCambridge, Massachusetts, United States calendar_todayFounded 2010 groups15 employees language navitorpharma.com

Registered entities

Investor mix

14 investors on record; lead investors include Brace Pharma Capital.

Investor typeCountShare
Venture capital1071%
Private equity17%
Accelerator & incubator17%
Other / undisclosed214%
Coming soon